Aurobindo Pharma to acquire 26% stake in Swarnaakshu Solar Power for captive renewable energy project

The acquisition structure aligns with India’s regulatory framework for captive power generation, which requires a minimum 26% ownership stake to qualify for associated benefits, including reduced power procurement costs through open access mechanisms. The transaction is expected to be completed by June 30, subject to the receipt of necessary regulatory approvals and fulfillment of customary conditions. This development reflects the increasing adoption of captive renewable energy solutions by energy-intensive industries in India, particularly as companies seek to improve cost efficiency, reduce exposure to grid tariff volatility, and align with evolving environmental, social, and governance (ESG) standards. Also Read   SP Energy Networks And The University Of Glasgow Launch Multi-Year Partnership To Build A Sector-Leading Cyber Defence Lab And Strengthen Net Zero Skills The move also highlights a broader industry trend, with corporates increasingly investing in renewable energy assets to support long-term operational sustainability and energy security.